Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

ALDER BIOPHARMACEUTICALS INC (ALDR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/24/2019 4 Campoy Carlos (CFO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Disposed/sold 270,000 options to buy @ $11.5, valued at $3.1M
10/24/2019 4 STRECK PAUL (Chief Medical Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 1,390 shares @ $9.2, valued at $12.8k
Disposed/sold 1,390 shares @ $18, valued at $25k
Disposed/sold 250,000 options to buy @ $13.41, valued at $3.4M
10/24/2019 4 Dac Nadia (Chief Commercial Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Disposed/sold 250,000 options to buy @ $13.9, valued at $3.5M
10/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2019 4 Lavelle Erin (COO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 11,684 shares @ $0
Unknown transaction of 16,092 shares @ $18, valued at $289.7k
Disposed/sold 300,000 options to buy @ $14.55, valued at $4.4M
Disposed/sold 150,000 options to buy @ $14, valued at $2.1M
10/24/2019 4 Bucher James B (EVP & General Counsel) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 1,345 shares @ $9.197, valued at $12.4k
Granted 904 shares @ $9.2, valued at $8.3k
Granted 15,619 shares @ $0
Unknown transaction of 27,677 shares @ $18, valued at $498.2k
Disposed/sold 95,000 options to buy @ $20.17, valued at $1.9M
Disposed/sold 50,000 options to buy @ $20.4, valued at $1M
Disposed/sold 35,000 options to buy @ $10.7, valued at $374.5k
Disposed/sold 70,000 options to buy @ $13.55, valued at $948.5k
Disposed/sold 70,000 options to buy @ $13.24, valued at $926.8k
Disposed/sold 135,000 options to buy @ $14, valued at $1.9M
10/24/2019 4 Hassler Randal (EVP, Pharmaceutical Ops.) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 14,346 shares @ $0
Disposed/sold 19,780 shares @ $18, valued at $356k
Disposed/sold 80,000 options to buy @ $11.79, valued at $943.2k
Disposed/sold 30,000 options to buy @ $28.23, valued at $846.9k
Disposed/sold 75,000 options to buy @ $24.18, valued at $1.8M
Disposed/sold 60,000 options to buy @ $20.4, valued at $1.2M
Disposed/sold 60,000 options to buy @ $10.7, valued at $642k
Disposed/sold 80,000 options to buy @ $13.55, valued at $1.1M
Disposed/sold 150,000 options to buy @ $14, valued at $2.1M
10/24/2019 4 Smith Jeffrey T L (Managing Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 16,230 shares @ $0
Disposed/sold 21,502 shares @ $18, valued at $387k
Disposed/sold 17,271 options to buy @ $3.465, valued at $59.8k
Disposed/sold 31,818 options to buy @ $3.465, valued at $110.2k
Disposed/sold 13,636 options to buy @ $6.765, valued at $92.2k
Disposed/sold 13,636 options to buy @ $10, valued at $136.4k
Disposed/sold 35,000 options to buy @ $16.9, valued at $591.5k
Disposed/sold 50,000 options to buy @ $28.23, valued at $1.4M
Disposed/sold 100,000 options to buy @ $24.18, valued at $2.4M
Disposed/sold 85,000 options to buy @ $20.4, valued at $1.7M
Disposed/sold 50,000 options to buy @ $10.7, valued at $535k
10/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2019 4 Preston Heather (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Disposed/sold 6,350 options to buy @ $39.66, valued at $251.8k
Disposed/sold 15,000 options to buy @ $29.26, valued at $438.9k
Disposed/sold 15,000 options to buy @ $16.9, valued at $253.5k
10/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2019 4 Carter Paul Rutherford (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Disposed/sold 30,000 options to buy @ $31.1, valued at $933k
Disposed/sold 15,000 options to buy @ $29.26, valued at $438.9k
Disposed/sold 15,000 options to buy @ $16.9, valued at $253.5k
Disposed/sold 15,000 options to buy @ $15.5, valued at $232.5k
Disposed/sold 22,500 options to buy @ $11.01, valued at $247.7k
10/24/2019 4 Azelby Robert (President and CEO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Disposed/sold 1,000,000 options to buy @ $16.2, valued at $16.2M
Disposed/sold 505,000 options to buy @ $14, valued at $7.1M
Disposed/sold 15,000 restricted stock units @ $0
Disposed/sold 150,000 options to buy @ $16.2, valued at $2.4M
10/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2019 3 H LUNDBECK A S (10% Owner) has filed a Form 3 on ALDER BIOPHARMACEUTICALS INC
09/18/2019 4 Smith Jeffrey T L (Managing Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Sold 32,728 shares @ $18.44, valued at $603.5k
Exercised 22,727 options to buy @ $4.455, valued at $101.2k
Exercised 10,001 options to buy @ $3.465, valued at $34.7k
07/01/2019 4 Redmile Group, LLC (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 19,023 options to buy @ $2622315.59, valued at $49884.3M
05/28/2019 4 YARNO WENDY L (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 22,500 options to buy @ $11.01, valued at $247.7k
05/28/2019 4 SIEGALL CLAY B (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 22,500 options to buy @ $11.01, valued at $247.7k
05/28/2019 4 Montgomery Alan Bruce (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 22,500 options to buy @ $11.01, valued at $247.7k
05/28/2019 4 Carter Paul Rutherford (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 22,500 options to buy @ $11.01, valued at $247.7k
05/28/2019 4 Cleveland Paul B (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 22,500 options to buy @ $11.01, valued at $247.7k
05/24/2019 4 Redmile Group, LLC (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 22,500 options to buy @ $11.01, valued at $247.7k
04/25/2019 4 Azelby Robert (President and CEO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 150,000 options to buy @ $16.2, valued at $2.4M
04/25/2019 4 Hassler Randal (EVP, Pharmaceutical Ops.) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 7,172 shares @ $0
Sold 1,738 shares @ $13.8475, valued at $24.1k
04/25/2019 4 Benedict Larry (EVP and PAO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 7,055 shares @ $0
Sold 1,734 shares @ $13.646, valued at $23.7k
04/25/2019 4 Smith Jeffrey T L (Managing Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 9,288 shares @ $0
Disposed/sold 4,847 shares @ $13.7251, valued at $66.5k
04/25/2019 4 Lavelle Erin (COO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 5,842 shares @ $0
Sold 1,434 shares @ $13.6676, valued at $19.6k
04/25/2019 4 Bucher James B (EVP & General Counsel) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 7,810 shares @ $0
Sold 1,897 shares @ $13.8539, valued at $26.3k
04/10/2019 4 Dac Nadia (Chief Commercial Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 250,000 options to buy @ $13.9, valued at $3.5M
04/10/2019 3 Dac Nadia (Chief Commercial Officer) has filed a Form 3 on ALDER BIOPHARMACEUTICALS INC
03/06/2019 4 Redmile Group, LLC (Director) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 1,739,130 shares @ $11.5, valued at $20M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy